Drugs Made In Stock Analysis
| DMAA Stock | 10.44 0.01 0.1% |
As of February 16, 2026, Debt To Equity is expected to decline to -2.57. In addition to that, Interest Debt Per Share is expected to decline to 0.000062 With a high degree of financial leverage come high-interest payments, which usually reduce Drugs Made's Earnings Per Share (EPS).
Given that Drugs Made's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Drugs Made is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Drugs Made to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Drugs Made is said to be less leveraged. If creditors hold a majority of Drugs Made's assets, the Company is said to be highly leveraged.
Drugs Made In is overvalued with Real Value of 8.75 and Hype Value of 10.44. The main objective of Drugs Made stock analysis is to determine its intrinsic value, which is an estimate of what Drugs Made In is worth, separate from its market price. There are two main types of Drugs Made's stock analysis: fundamental analysis and technical analysis.
The Drugs Made stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Drugs Made's ongoing operational relationships across important fundamental and technical indicators.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Drugs Made In. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Drugs Stock Analysis Notes
About 27.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. To learn more about Drugs Made In call Lynn Stockwell at 954 870 3099 or check out https://dmaacorp.com.Drugs Made In Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Drugs Made's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Drugs Made In or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Drugs Made In has a very weak financial position based on the latest SEC disclosures | |
| About 71.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: BridgeBios Most Hotly Debated Drug Scores Big In Phase 3 - Investors Business Daily |
Drugs Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 349.92 M.Drugs Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.78) | (0.82) | |
| Return On Capital Employed | 1.76 | 1.57 | |
| Return On Assets | (0.78) | (0.82) | |
| Return On Equity | 1.77 | 1.57 |
Technical Drivers
As of the 16th of February 2026, Drugs Made shows the Mean Deviation of 0.0783, coefficient of variation of 636.09, and Standard Deviation of 0.1118. Drugs Made In technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Drugs Made In Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Drugs Made middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Drugs Made In. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Drugs Made In Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Drugs Made insiders, such as employees or executives, is commonly permitted as long as it does not rely on Drugs Made's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Drugs Made insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lynn Stockwell over three months ago Disposition of 5698363 shares by Lynn Stockwell of Drugs Made at 1.5 subject to Rule 16b-3 | ||
Stockwell Lynn over six months ago Acquisition by Stockwell Lynn of 30000 shares of Drugs Made subject to Rule 16b-3 |
Drugs Made Outstanding Bonds
Drugs Made issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Drugs Made In uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Drugs bonds can be classified according to their maturity, which is the date when Drugs Made In has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Drugs Made Predictive Daily Indicators
Drugs Made intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Drugs Made stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Drugs Made Corporate Filings
8K | 18th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 17th of November 2025 Other Reports | ViewVerify | |
13A | 12th of November 2025 An amended filing to the original Schedule 13G | ViewVerify |
13A | 14th of August 2025 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 20th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
13A | 15th of May 2025 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 14th of May 2025 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Drugs Made Forecast Models
Drugs Made's time-series forecasting models are one of many Drugs Made's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Drugs Made's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Drugs Made Bond Ratings
Drugs Made In financial ratings play a critical role in determining how much Drugs Made have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Drugs Made's borrowing costs.Drugs Made Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Drugs Made uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Drugs Made Debt Ratio | 96.0 |
Drugs Made Corporate Bonds Issued
Most Drugs bonds can be classified according to their maturity, which is the date when Drugs Made In has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Drugs Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Drugs Made prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Drugs shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Drugs Made. By using and applying Drugs Stock analysis, traders can create a robust methodology for identifying Drugs entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Drugs Made to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |